PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze analyst forecasts for the company and compare them with competitors.
42.52K
Worse than RIGL's estimated revenue of 171.80M.
-8.50K
Better than RIGL's estimated ebitda of -26.28M.
-1.41
Worse than RIGL's estimated eps of 0.39.
-41.31M
Worse than RIGL's estimated net income of 6.57M.
-8.50K
Better than RIGL's estimated ebit of -27.84M.
1.58M
Better than RIGL's estimated sg&a expense of 130.27M.
Analyze DCF forecasts for the company and compare them with competitors.
1.03M
Worse than RIGL's revenue of 120.24M.
-9.97%
Better than RIGL's revenue growth rate of -19.43%.
-33.41M
Better than RIGL's ebitda of -53.87M.
-3243.20%
Worse than RIGL's ebitda margin of -44.80%.
-34.10M
Better than RIGL's ebit of -54.87M.
-3311.07%
Worse than RIGL's ebit margin of -45.63%.
699.00K
Better than RIGL's depreciation of 998.00K.
108.91M
Better than RIGL's total cash of 58.21M.
10573.79%
Better than RIGL's cash as percentage of revenue of 48.41%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
10.13M
Better than RIGL's accounts payable of 22.51M.
983.50%
Worse than RIGL's payables as percentage of revenue of 18.72%.
-366.00K
Worse than RIGL's capital expenditure of -450.00K.
-35.53%
Better than RIGL's capex as percentage of revenue of -0.37%.
4.99%
Better than RIGL's weighted average cost of capital (wacc) of 10.78%.
5.02%
Better than RIGL's cost of equity of 10.36%.
4.08%
Better than RIGL's cost of debt of 13.20%.
-0.23
Better than RIGL's beta of 1.33.
30.07M
Worse than RIGL's diluted shares outstanding of 17.69M.
1.57M
Better than RIGL's total debt of 59.97M.
49.31M
Worse than RIGL's total equity of 350.82M.
50.89M
Worse than RIGL's total capital of 410.79M.
3.09%
Better than RIGL's debt weighting of 14.60%.
96.91%
Better than RIGL's equity weighting of 85.40%.
-32.98M
Better than RIGL's ebiat of -57.70M.
-28.05M
Better than RIGL's unlevered free cash flow of -65.79M.
2.00%
Equal to RIGL's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than RIGL's net debt of 3.22M.
71.33M
Better than RIGL's equity value of -795.30M.
2.37
Better than RIGL's equity value per share of -44.97.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.